Retinal & OCT Imaging
Buy and sell retinal & oct imaging data. Fundus photos, OCT scans, fluorescein angiography — ophthalmology AI can detect diabetic retinopathy and glaucoma from your eye clinic's archives.
Overview
What Is Retinal & OCT Imaging Data?
Retinal and OCT (Optical Coherence Tomography) imaging data encompasses fundus photographs, OCT scans, fluorescein angiography images, and other high-resolution cross-sectional retinal images captured from eye clinics and hospitals. These datasets are essential for training artificial intelligence models to detect and classify retinal diseases such as diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, and diabetic macular edema. OCT has become the dominant imaging modality in ophthalmology, providing detailed visualization of neural tissue and vascular structures with resolutions sufficient to detect pathologies in early stages. The market for AI-driven retinal imaging and OCT technology is expanding rapidly, driven by rising prevalence of eye diseases, increased adoption in clinical practice, and growing investment in non-invasive diagnostic tools.
Market Data
$1.84 billion
AI OCT Market Size (2024)
Source: Research and Markets
$1.9 billion
AI-Driven Retinal Screening Market (2024)
Source: Global Market Insights
$3.71 billion
Projected OCT Market (2031)
Source: Mordor Intelligence
35+ million
Global Annual Retinal OCT Scans
Source: DataIntelo
12.3%
AI OCT Market CAGR (2024-2025)
Source: Research and Markets
Who Uses This Data
What AI models do with it.do with it.
Diabetic Retinopathy Detection
AI models trained on fundus and OCT images to screen for diabetic retinopathy, one of the leading causes of vision loss in diabetic patients. Clinical guidelines mandate OCT-based assessment for diabetic macular edema diagnosis and monitoring.
Glaucoma and Age-Related Macular Degeneration (AMD)
Retinal imaging datasets support AI development for early detection and classification of glaucoma, AMD, and related conditions. OCT provides detailed cross-sectional imaging critical for staging disease severity.
Clinical Research and Algorithm Validation
Research institutions and medical device companies use labeled OCT and fundus datasets to train, validate, and benchmark deep learning models for retinal disease classification across multiple pathologies.
Myopia and Choroidal Assessment
OCT-A (angiography) sub-segment growing at 13.1% CAGR, particularly in Asia Pacific for myopia management and detailed choroidal structural assessment in clinical practice.
What Can You Earn?
What it's worth.worth.
Research Reports & Market Analysis
€4,034–USD $4,490
Commercial market intelligence reports on OCT and retinal imaging market sizing and forecasts.
Labeled OCT Datasets
Varies
Pricing depends on dataset size, disease categories, imaging equipment provenance, and exclusivity terms. Published open-access datasets range from thousands to tens of thousands of labeled images.
Clinical Imaging Archives
Varies
Licensed de-identified fundus photos, OCT scans, and angiography from eye clinics and hospitals command premium pricing based on patient volume, disease diversity, and regulatory compliance documentation.
What Buyers Expect
What makes it valuable.valuable.
High-Resolution Image Quality
Fundus and OCT images must meet clinical diagnostic standards. Common systems include Heidelberg Engineering Spectralis and Zeiss Cirrus, which provide high-resolution and wide-spectrum imaging. Resolution ranges from 2,048 × 1,536 pixels to 4,288 × 2,848 pixels depending on device and modality.
Comprehensive Disease Labeling
Images must be annotated with specific retinal conditions including diabetic retinopathy, AMD, glaucoma, diabetic macular edema, epiretinal membrane, macular hole, and central serous chorioretinopathy. Datasets should reflect real-world diagnostic complexity including both high and low-quality images.
De-Identification and Compliance
All personal health information must be removed according to HIPAA and regional privacy regulations. Clinical metadata (age, diagnosis codes, imaging parameters) should be preserved in compliant formats for model training.
Statistical Balance and Train-Test Splits
Datasets should follow standard ML conventions: 75% training, 15% validation, 15% testing. Adequate representation across disease categories and demographic groups to prevent model bias.
Companies Active Here
Who's buying.buying.
Develops advanced OCT and retinal imaging systems; acquires imaging data to refine diagnostic algorithms and train AI models for disease detection.
Major OCT device manufacturer producing high-resolution retinal imaging equipment; invests in AI-based retinal screening tools integrated with OCT datasets.
Manufactures ultra-widefield retinal imaging systems; leverages OCT and fundus datasets for algorithm development in retinal disease screening.
AI-focused ophthalmic company specializing in retinal screening; actively sources labeled fundus and OCT datasets to train diabetic retinopathy detection models.
End-user segment acquiring OCT devices and contributing clinical imaging data through partnerships with AI developers for real-world model validation and deployment.
FAQ
Common questions.questions.
What types of retinal imaging are included in this data category?
Retinal and OCT imaging data includes fundus photographs (color and grayscale), OCT (Optical Coherence Tomography) scans, OCT angiography (OCT-A), fluorescein angiography images, confocal scanning laser ophthalmoscope (cSLO) images, and retinal photography systems. OCT has become the leading product type segment in the global retinal imaging market.
Which diseases can AI detect using retinal imaging data?
AI models trained on retinal and OCT datasets can detect diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, diabetic macular edema, retinal vessel occlusions, epiretinal membrane, macular hole, and central serous chorioretinopathy. Over 35 million retinal OCT scans are performed globally each year to support these clinical applications.
What is the current market size and growth rate for OCT and retinal imaging?
The AI OCT market was valued at $1.84 billion in 2024 and is projected to reach $2.06 billion in 2025 at a 12.3% CAGR. The broader OCT market is expected to grow from $2.19 billion in 2026 to $3.71 billion in 2031 at an 11.13% CAGR. AI-driven retinal screening devices are forecast to grow from $2.2 billion in 2025 to $6.1 billion in 2034.
What equipment standards should retinal imaging data meet?
High-quality retinal imaging data is typically captured using Heidelberg Engineering Spectralis or Zeiss Cirrus OCT systems, which provide high-resolution and wide-spectrum images. Image resolutions range from 2,048 × 1,536 pixels to 4,288 × 2,848 pixels depending on the device. Datasets should include both high and low-quality images to reflect real-world clinical variability and improve AI model robustness.
Sell yourretinal & oct imagingdata.
If your company generates retinal & oct imaging, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation